Jerome D. Jabbour
Overview
Jerome D. Jabbour received an average of $2M in total compensation, including $398K in salary, at Matinas BioPharma Holdings from 2014 to 2022.
2022Matinas BioPharma HoldingsChief Executive Officer
2021Matinas BioPharma HoldingsChief Executive Officer
2020Matinas BioPharma HoldingsChief Executive Officer
2019Matinas BioPharma HoldingsChief Executive Officer
2018Matinas BioPharma HoldingsChief Executive Officer
2017Matinas BioPharma HoldingsChief Executive Officer and President
2016Matinas BioPharma HoldingsPresident
2015Matinas BioPharma HoldingsPresident
2014Matinas BioPharma HoldingsPresident
Source: SEC filings on September 19, 2023, September 22, 2022, October 1, 2020, September 24, 2019, September 24, 2018, September 14, 2017, and September 22, 2016.
Related executives
We found nine more executives who work or worked at Matinas BioPharma Holdings.
James Ferguson
Matinas BioPharma Holdings
Chief Medical Officer
Theresa Matkovits
Matinas BioPharma Holdings
Chief Development Officer
Keith Kucinski
Matinas BioPharma Holdings
Chief Financial Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
Douglas Kling
Matinas BioPharma Holdings
Senior Vice President, Clinical Development & Project Management
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019